Review



rabbit anti bub1  (Bethyl)


Bioz Verified Symbol Bethyl is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Bethyl rabbit anti bub1
    Rabbit Anti Bub1, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 47 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti bub1/product/Bethyl
    Average 93 stars, based on 47 article reviews
    rabbit anti bub1 - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    rabbit anti bub1  (Bethyl)
    93
    Bethyl rabbit anti bub1
    Rabbit Anti Bub1, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti bub1/product/Bethyl
    Average 93 stars, based on 1 article reviews
    rabbit anti bub1 - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    rabbit anti-bub1-pt609 antibody  (Biomatik)
    90
    Biomatik rabbit anti-bub1-pt609 antibody
    Rabbit Anti Bub1 Pt609 Antibody, supplied by Biomatik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-bub1-pt609 antibody/product/Biomatik
    Average 90 stars, based on 1 article reviews
    rabbit anti-bub1-pt609 antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    rabbit anti-bub1-pt609  (Biomatik)
    90
    Biomatik rabbit anti-bub1-pt609
    Rabbit Anti Bub1 Pt609, supplied by Biomatik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-bub1-pt609/product/Biomatik
    Average 90 stars, based on 1 article reviews
    rabbit anti-bub1-pt609 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    rabbit anti-human bub1 monoclonal antibody  (Sanying Ltd)
    90
    Sanying Ltd rabbit anti-human bub1 monoclonal antibody
    Analysis of <t>BUB1</t> and BUB1B gene differential expression in tumors. ( A ) Analysis of BUB1 gene expression in tumors in TIMER 2.0 database; ( B ) Analysis of BUB1 gene expression analysis in tumors in GEPIA2 database; ( C ) Analysis of BUB1B gene expression analysis in tumors in TIMER 2.0 database; ( D ) Analysis of BUB1B gene expression analysis in tumors in GEPIA2 database. * P < 0.05.
    Rabbit Anti Human Bub1 Monoclonal Antibody, supplied by Sanying Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human bub1 monoclonal antibody/product/Sanying Ltd
    Average 90 stars, based on 1 article reviews
    rabbit anti-human bub1 monoclonal antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    rabbit anti-bub1  (Beyotime)
    90
    Beyotime rabbit anti-bub1
    Analysis of <t>BUB1</t> and BUB1B gene differential expression in tumors. ( A ) Analysis of BUB1 gene expression in tumors in TIMER 2.0 database; ( B ) Analysis of BUB1 gene expression analysis in tumors in GEPIA2 database; ( C ) Analysis of BUB1B gene expression analysis in tumors in TIMER 2.0 database; ( D ) Analysis of BUB1B gene expression analysis in tumors in GEPIA2 database. * P < 0.05.
    Rabbit Anti Bub1, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-bub1/product/Beyotime
    Average 90 stars, based on 1 article reviews
    rabbit anti-bub1 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Analysis of BUB1 and BUB1B gene differential expression in tumors. ( A ) Analysis of BUB1 gene expression in tumors in TIMER 2.0 database; ( B ) Analysis of BUB1 gene expression analysis in tumors in GEPIA2 database; ( C ) Analysis of BUB1B gene expression analysis in tumors in TIMER 2.0 database; ( D ) Analysis of BUB1B gene expression analysis in tumors in GEPIA2 database. * P < 0.05.

    Journal: Scientific Reports

    Article Title: Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer

    doi: 10.1038/s41598-024-67528-2

    Figure Lengend Snippet: Analysis of BUB1 and BUB1B gene differential expression in tumors. ( A ) Analysis of BUB1 gene expression in tumors in TIMER 2.0 database; ( B ) Analysis of BUB1 gene expression analysis in tumors in GEPIA2 database; ( C ) Analysis of BUB1B gene expression analysis in tumors in TIMER 2.0 database; ( D ) Analysis of BUB1B gene expression analysis in tumors in GEPIA2 database. * P < 0.05.

    Article Snippet: Samples were incubated with primary antibody (rabbit anti-human BUB1 and BUBIB monoclonal antibody, 1:200) (Sanying Biotechnology Co. Ltd., Wuhan, Hubei, China), followed by incubation with secondary antibody (HRP-labeled goat anti-rabbit II antibody, 1:200) (Zhongshan Jinqiao Biotechnology Co. Ltd., Beijing, China).

    Techniques: Quantitative Proteomics, Gene Expression

    BUB1 and BUB1B expression in EC. ( A ) BUB1 expression in normal endometrium and EC (XianTao database); ( B ) BUB1 expression in normal endometrium and EC (IHC); ( C ) BUB1B expression in normal endometrium and EC (XiaoTao database); ( D ) BUB1B expression in normal endometrium and EC (IHC); ( E ) BUB1 ROC curve in EC; ( F ) BUB1B ROC curve in EC.

    Journal: Scientific Reports

    Article Title: Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer

    doi: 10.1038/s41598-024-67528-2

    Figure Lengend Snippet: BUB1 and BUB1B expression in EC. ( A ) BUB1 expression in normal endometrium and EC (XianTao database); ( B ) BUB1 expression in normal endometrium and EC (IHC); ( C ) BUB1B expression in normal endometrium and EC (XiaoTao database); ( D ) BUB1B expression in normal endometrium and EC (IHC); ( E ) BUB1 ROC curve in EC; ( F ) BUB1B ROC curve in EC.

    Article Snippet: Samples were incubated with primary antibody (rabbit anti-human BUB1 and BUBIB monoclonal antibody, 1:200) (Sanying Biotechnology Co. Ltd., Wuhan, Hubei, China), followed by incubation with secondary antibody (HRP-labeled goat anti-rabbit II antibody, 1:200) (Zhongshan Jinqiao Biotechnology Co. Ltd., Beijing, China).

    Techniques: Expressing

    BUB1 and BUB1B gene variations in EC. ( A ) BUB1 gene alteration in EC; ( B ) BUB1 gene alteration in relation to OS in EC; ( C ) BUB1 gene alteration in relation to PFS in EC. ( D ) BUB1B gene alteration in EC; € BUB1B gene alteration in relation to OS in EC; F. BUB1B gene alteration in relation to PFS in EC.

    Journal: Scientific Reports

    Article Title: Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer

    doi: 10.1038/s41598-024-67528-2

    Figure Lengend Snippet: BUB1 and BUB1B gene variations in EC. ( A ) BUB1 gene alteration in EC; ( B ) BUB1 gene alteration in relation to OS in EC; ( C ) BUB1 gene alteration in relation to PFS in EC. ( D ) BUB1B gene alteration in EC; € BUB1B gene alteration in relation to OS in EC; F. BUB1B gene alteration in relation to PFS in EC.

    Article Snippet: Samples were incubated with primary antibody (rabbit anti-human BUB1 and BUBIB monoclonal antibody, 1:200) (Sanying Biotechnology Co. Ltd., Wuhan, Hubei, China), followed by incubation with secondary antibody (HRP-labeled goat anti-rabbit II antibody, 1:200) (Zhongshan Jinqiao Biotechnology Co. Ltd., Beijing, China).

    Techniques:

    BUB1 or BUB1B and EC immune filtration. ( A ) BUB1 expression was associated with TIL abundance in EC; ( B ) BUB1 expression was associated with immunosuppressants in EC; ( C ) BUB1 expression and immunostimulants in EC. ( D ) BUB1B expression was associated with TIL abundance in EC; E. BUB1B expression was associated with immunosuppressants in EC; ( F ) BUB1B expression and immunostimulants in EC.

    Journal: Scientific Reports

    Article Title: Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer

    doi: 10.1038/s41598-024-67528-2

    Figure Lengend Snippet: BUB1 or BUB1B and EC immune filtration. ( A ) BUB1 expression was associated with TIL abundance in EC; ( B ) BUB1 expression was associated with immunosuppressants in EC; ( C ) BUB1 expression and immunostimulants in EC. ( D ) BUB1B expression was associated with TIL abundance in EC; E. BUB1B expression was associated with immunosuppressants in EC; ( F ) BUB1B expression and immunostimulants in EC.

    Article Snippet: Samples were incubated with primary antibody (rabbit anti-human BUB1 and BUBIB monoclonal antibody, 1:200) (Sanying Biotechnology Co. Ltd., Wuhan, Hubei, China), followed by incubation with secondary antibody (HRP-labeled goat anti-rabbit II antibody, 1:200) (Zhongshan Jinqiao Biotechnology Co. Ltd., Beijing, China).

    Techniques: Filtration, Expressing

    The relation between BUB1 and BUB1B expression with clinicopathological characteristics in EC.

    Journal: Scientific Reports

    Article Title: Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer

    doi: 10.1038/s41598-024-67528-2

    Figure Lengend Snippet: The relation between BUB1 and BUB1B expression with clinicopathological characteristics in EC.

    Article Snippet: Samples were incubated with primary antibody (rabbit anti-human BUB1 and BUBIB monoclonal antibody, 1:200) (Sanying Biotechnology Co. Ltd., Wuhan, Hubei, China), followed by incubation with secondary antibody (HRP-labeled goat anti-rabbit II antibody, 1:200) (Zhongshan Jinqiao Biotechnology Co. Ltd., Beijing, China).

    Techniques: Expressing

    Influence of BUB1 and BUBIB knockdown on EC cell phenotype. ( A ) The growth of Ishikawa cells in each group; ( B ) The migration rates of Ishikawa cells in each group: blank group (50.99 ± 1.02)%, NC-siRNA group (66.50 ± 7.74)%, BUB1-siRNA group (34.87 ± 4.26)%, and BUB1B-siRNA group (31.96 ± 4.72)%; ( C ) The number of cells that crossed the membrane in each group: blank group (127.3 ± 4.8), NC-siRNA group (125.3 ± 3.9), BUB1-siRNA group (48.6 ± 3.2), and BUB1B-siRNA group (35.0 ± 2.1). * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: Scientific Reports

    Article Title: Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer

    doi: 10.1038/s41598-024-67528-2

    Figure Lengend Snippet: Influence of BUB1 and BUBIB knockdown on EC cell phenotype. ( A ) The growth of Ishikawa cells in each group; ( B ) The migration rates of Ishikawa cells in each group: blank group (50.99 ± 1.02)%, NC-siRNA group (66.50 ± 7.74)%, BUB1-siRNA group (34.87 ± 4.26)%, and BUB1B-siRNA group (31.96 ± 4.72)%; ( C ) The number of cells that crossed the membrane in each group: blank group (127.3 ± 4.8), NC-siRNA group (125.3 ± 3.9), BUB1-siRNA group (48.6 ± 3.2), and BUB1B-siRNA group (35.0 ± 2.1). * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Samples were incubated with primary antibody (rabbit anti-human BUB1 and BUBIB monoclonal antibody, 1:200) (Sanying Biotechnology Co. Ltd., Wuhan, Hubei, China), followed by incubation with secondary antibody (HRP-labeled goat anti-rabbit II antibody, 1:200) (Zhongshan Jinqiao Biotechnology Co. Ltd., Beijing, China).

    Techniques: Knockdown, Migration, Membrane